Literature DB >> 24217128

Antibacterial activity of moxifloxacin on bacteria associated with periodontitis within a biofilm.

Phoebus Tsaousoglou1, Sandor Nietzsche2, Georg Cachovan3, Anton Sculean1, Sigrun Eick1.   

Abstract

The activity of moxifloxacin was compared with ofloxacin and doxycycline against bacteria associated with periodontitis within a biofilm (single strain and mixed population) in vitro. MICs and minimal bactericidal concentrations (MBCs) of moxifloxacin, ofloxacin and doxycyline were determined against single strains and mixed populations in a planktonic state. Single-species biofilms of two Porphyromonas gingivalis and two Aggregatibacter actinomycetemcomitans strains and a multispecies biofilm consisting of 12 species were formed for 3 days. The minimal biofilm eradication concentrations (MBECs) were determined after exposing the biofilms to the antibacterials (0.002-512 µg ml(-1)) for 18 h, addition of nutrient broth for 3 days and subsequent subcultivation. Photographs were taken using confocal laser-scanning microscopy and scanning electron microscopy. The MICs and MBCs did not differ between ofloxacin and moxifloxacin against A. actinomycetemcomitans, whilst moxifloxacin was more active than the other tested antibacterials against anaerobes and the mixed population. The single-species biofilms were eradicated by moderate concentrations of the antibacterials, and the lowest MBECs were always found for moxifloxacin (2-8 µg ml(-1)). MBECs against the multispecies biofilms were 128, >512 and >512 µg ml(-1) for moxifloxacin, ofloxacin and doxycycline, respectively. In summary, moxifloxacin in a topical formulation may have potential as an adjunct to mechanical removal of the biofilms.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24217128     DOI: 10.1099/jmm.0.065441-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  10 in total

1.  Microbiological analysis and the outcomes of periodontal treatment with or without adjunctive systemic antibiotics-a retrospective study.

Authors:  Sigrun Eick; Jasmin Nydegger; Walter Bürgin; Giovanni E Salvi; Anton Sculean; Christoph Ramseier
Journal:  Clin Oral Investig       Date:  2018-02-21       Impact factor: 3.573

2.  Nonsurgical therapy of chronic periodontitis with adjunctive systemic azithromycin or amoxicillin/metronidazole.

Authors:  Holger F R Jentsch; Andreas Buchmann; Abel Friedrich; Sigrun Eick
Journal:  Clin Oral Investig       Date:  2015-12-19       Impact factor: 3.573

3.  Novel multifunctional dental bonding agent for Class-V restorations to inhibit periodontal biofilms.

Authors:  Lin Wang; Chunyan Li; Michael D Weir; Ke Zhang; Yanmin Zhou; Hockin H K Xu; Mark A Reynolds
Journal:  RSC Adv       Date:  2017-06-02       Impact factor: 3.361

4.  A multilevel analysis of a randomized clinical trial comparing adjunctive moxifloxacin versus amoxicillin/metronidazole for the treatment of aggressive periodontitis.

Authors:  Carlos-Martín Ardila; Jader-Alexander Bedoya-García
Journal:  Dent Res J (Isfahan)       Date:  2021-06-22

5.  In vitro activity of taurolidine gel on bacteria associated with periodontitis.

Authors:  Sigrun Eick; Nicoletta Gloor; Cecilia Püls; Jürg Zumbrunn; Anton Sculean
Journal:  Clin Oral Investig       Date:  2015-08-09       Impact factor: 3.573

6.  Systemic moxifloxacin vs amoxicillin/metronidazole adjunct to non-surgical treatment in generalized aggressive periodontitis.

Authors:  Esra Guzeldemir-Akcakanat; Cem-Abdulkadir Gurgan
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2015-07-01

7.  A Biofilm Pocket Model to Evaluate Different Non-Surgical Periodontal Treatment Modalities in Terms of Biofilm Removal and Reformation, Surface Alterations and Attachment of Periodontal Ligament Fibroblasts.

Authors:  Tobias T Hägi; Sabrina Klemensberger; Riccarda Bereiter; Sandor Nietzsche; Raluca Cosgarea; Simon Flury; Adrian Lussi; Anton Sculean; Sigrun Eick
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

8.  Quantitative proteomics reveal distinct protein regulations caused by Aggregatibacter actinomycetemcomitans within subgingival biofilms.

Authors:  Kai Bao; Nagihan Bostanci; Nathalie Selevsek; Thomas Thurnheer; Georgios N Belibasakis
Journal:  PLoS One       Date:  2015-03-10       Impact factor: 3.240

Review 9.  Diabetes mellitus related bone metabolism and periodontal disease.

Authors:  Ying-Ying Wu; E Xiao; Dana T Graves
Journal:  Int J Oral Sci       Date:  2015-06-26       Impact factor: 6.344

10.  In Vitro Antibacterial Activity of Myrtus communis L. and Marrubium vulgare L. Leaves against Aggregatibacter actinomycetemcomitans and Eikenella corrodens.

Authors:  Kaoutar Dib; Yahia Cherrah; Sana Rida; Abdelkarim Filali-Maltouf; OumKeltoum Ennibi
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-19       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.